Mark A. Kay
Director/Board Member at Genevant Sciences Corp.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jonathan Quick | M | - | 5 years | |
| Frédéric Chéreau | M | 57 | 8 years | |
| Bo Rode Hansen | M | - |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | - |
| Michael Snyder | M | - |
Stanford University School of Medicine
| 15 years |
| Marie Payton | F | - | 5 years | |
| Bruno C. Medeiros | M | - |
Stanford University School of Medicine
| - |
| William Collier | M | 64 |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | - |
| John W. Day | M | - |
Stanford University School of Medicine
| 13 years |
| Matthias Hebben | M | - | 5 years | |
| Vikram Bajaj | M | 46 |
Stanford University School of Medicine
| 10 years |
| Oliver Dorigo | M | - |
Stanford University School of Medicine
| - |
| Simon Stertzer | M | 88 |
Stanford University School of Medicine
| 26 years |
| Philip Hanno | M | - |
Stanford University School of Medicine
| 8 years |
| Calvin J. Kuo | M | - |
Stanford University School of Medicine
| - |
| Walter Greenleaf | M | - |
Stanford University School of Medicine
| 7 years |
| George W. Sledge | M | 73 |
Stanford University School of Medicine
| - |
| Alejandro Dorenbaum | M | 64 |
Stanford University School of Medicine
| - |
| Michael Franken | M | 59 | 3 years | |
| Sandra Horning | M | 75 |
Stanford University School of Medicine
| - |
| Joseph Wolk | M | 57 |
Stanford University School of Medicine
| - |
| Ryan Spitler | M | - |
Stanford University School of Medicine
| 8 years |
| Stefan Heller | M | 58 |
Stanford University School of Medicine
| - |
| Theodore Tussing | M | - |
Stanford University School of Medicine
| - |
| Janice Olson | F | - | 3 years | |
| Hannah Valantine | M | 72 |
Stanford University School of Medicine
| 37 years |
| Kiki Chang | M | - |
Stanford University School of Medicine
| - |
| Henry Greely | M | - |
Stanford University School of Medicine
| - |
| Gary Berke | M | - |
Stanford University School of Medicine
| - |
| Susan Hoerger | F | - |
Stanford University School of Medicine
| - |
| Phil Yang | M | - |
Stanford University School of Medicine
| - |
| Judith Ned | F | - |
Stanford University School of Medicine
| - |
| Christi Opitz | F | - |
Stanford University School of Medicine
| - |
| Chris Zeise | M | - |
Stanford University School of Medicine
| - |
| Jennifer Rosingana | F | - |
Stanford University School of Medicine
| - |
| Grace Lochhead | F | - | 3 years | |
| Mintu Turakhia | M | 50 |
Stanford University School of Medicine
| 16 years |
| Glenn Matthew Chertow | M | - |
Stanford University School of Medicine
| - |
| Stephen Galli | M | 77 |
Stanford University School of Medicine
| 25 years |
| Sachie Oshima | M | 52 |
Stanford University School of Medicine
| 17 years |
| Eugene Bauer | M | 81 |
Stanford University School of Medicine
| 36 years |
| Emmett Cunningham | M | 63 |
Stanford University School of Medicine
| 16 years |
| Mark J. Murray | M | 75 |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | - |
| Peter A. Zorn | M | 53 |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | 5 years |
| David Karpf | M | 69 |
Stanford University School of Medicine
| - |
| Joseph Wu | M | - |
Stanford University School of Medicine
| 11 years |
| George Tidmarsh | M | 64 |
Stanford University School of Medicine
| 14 years |
| Ramon Chavez Márquez | M | 60 |
Stanford University School of Medicine
| 9 years |
| Michelle Brandt | F | - |
Stanford University School of Medicine
| - |
| Lucy Shapiro | M | 83 |
Stanford University School of Medicine
| 35 years |
| Peter Fitzgerald | M | 66 |
Stanford University School of Medicine
| 27 years |
| Lawrence Steinman | M | 76 |
Stanford University School of Medicine
| - |
| Edgar Engleman | M | 78 |
Stanford University School of Medicine
| 34 years |
| Paul A. Berg | M | 97 |
Stanford University School of Medicine
| - |
| Steven J. Chu | M | 76 |
Stanford University School of Medicine
| 11 years |
| Peter Kim | M | 65 |
Stanford University School of Medicine
| 10 years |
| Christopher Viehbacher | M | 64 |
Stanford University School of Medicine
| - |
| Daria Mochly-Rosen | M | - |
Stanford University School of Medicine
| - |
| William J. Maloney | M | - |
Stanford University School of Medicine
| 20 years |
| Emmet B. Keeffe | M | - |
Stanford University School of Medicine
| - |
| Thomas C. Südhof | M | 68 |
Stanford University School of Medicine
| - |
| Eddie C. Cheung | M | - |
Stanford University School of Medicine
| - |
| Jeffrey Glenn | M | 61 |
Stanford University School of Medicine
| 24 years |
| K. Christopher Garcia | M | - |
Stanford University School of Medicine
| 25 years |
| Jillian Manus | F | - |
Stanford University School of Medicine
| 6 years |
| Paul Blumenthal | M | - |
Stanford University School of Medicine
| - |
| Thomas Krummel | M | 72 |
Stanford University School of Medicine
| - |
| James Newman | M | - |
Stanford University School of Medicine
| - |
| Roger Kornberg | M | 76 |
Stanford University School of Medicine
| 46 years |
| Frank Torti | M | 45 |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | - |
| Amato Giaccia | M | 65 |
Stanford University School of Medicine
| - |
| Thomas Raffin | M | 77 |
Stanford University School of Medicine
| - |
| Lawrence M. Shuer | M | - |
Stanford University School of Medicine
| - |
| Terrence Blaschke | M | 81 |
Stanford University School of Medicine
| 50 years |
| Garry Nolan | M | 63 |
Stanford University School of Medicine
| - |
| James Gillespie | M | - |
Stanford University School of Medicine
| 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cecilia Jones | F | 49 | 1 years | |
| Richard A. Moscicki | M | 72 | 4 years | |
| Farzad Soleimani | M | - |
Stanford University School of Medicine
| 5 years |
| Bryan Yoon | M | 46 | 1 years | |
| Leszek Lisowski | M | - | - | |
| Michael Wyzga | M | 69 | 4 years | |
| Susan R. Kahn | F | 67 | 1 years | |
| Andrea Paul | F | 43 | - | |
| Kyle Chiang | M | 44 | 5 years | |
| Themasap Khan | M | - |
Stanford University School of Medicine
| 5 years |
| Daniel O’Connell | M | 44 | 3 years | |
| Adi Barzel | M | - | 4 years | |
| Brian Luque | M | - | - | |
| Mark Chao | M | - |
Stanford University School of Medicine
| 7 years |
| Sofia Ioannidou | M | 45 | 2 years | |
| Erez Chimovits | M | 60 | 4 years | |
| Leon E. Chen | M | 49 | 6 years | |
| Tomer Kariv | M | 62 | 3 years | |
| Mark Enyedy | M | 60 | 2 years | |
| J. Goater | M | 48 | 2 years | |
| Daphne Karydas | F | 49 | 2 years | |
| Matthias B. Jaffé | M | 50 | 3 years | |
| Joshua Blacher | M | 52 | - | |
| Kevin Li | M | - |
Stanford University School of Medicine
| 4 years |
| Paul Herzich | M | 46 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 95.00% |
| Canada | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark A. Kay
- Personal Network
